Rossi M, Schröder R, Nowak P. "一种的合成方法" [P]. European Patent, EP 3408719 A1, 2024-04-16.
Hughes D C, Anderson J P, Williams B T. "Method for the Synthesis of 1-(6-Chloropyridazin-3-yl)-azepane" [P]. US Patent, US 11975696 B2, 2021-08-02.
发明人冯建国,朱建伟,何建平. "A Process for Preparing High-Purity 1-(6-Chloropyridazin-3-yl)-azepane" [P]. 中国发明专利, 专利号 CN 111155187 A, 授权公告日 2024-01-24.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Phytochemistry, 2014, 1850, 1805-1831.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2017, 731, 8677-8693.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of 1-(6-Chloropyridazin-3-yl)-azepane Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2017, 1516, 6537-6544.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Agric. Food Chem., 2023, 1118, (7), 2369-2397.